The FDA has not approved any microneedle patch containing GLP-1 or Semaglutide for over-the-counter weight loss
We may adjust your treatment plan or guide to help you feel more comfortable while continuing your weight loss journey safely and effectively
After Ozempic went viral on social media earlier this year for its ability to help people lose weight, skyrocketing demand led to occasional supply shortages - and concerns that people without diabetes or obesity were using it to shed a few kilos
Germany Focuses on Private Sector Treatment Access Demand for obesity GLP-1 treatment in Germany is projected to grow at a CAGR of 19.6%, constrained by statutory health insurance exclusions for anti-obesity medications that limit public reimbursement
Emerging Research Areas Cardiovascular Research: Recent studies explore the cardiovascular effects of glp3 peptide compounds, investigating their potential impact on heart health and vascular function
On the other hand, Liraglutide, which requires daily injections, may be more suited to patients who need more immediate effects due to its shorter half-life but are comfortable with daily injections
